default author photo

Marjolein Y.V. Homs

Erasmus University Medical Center Rotterdam - Medical Oncology

SCHOLARLY PAPERS

3

DOWNLOADS

163

TOTAL CITATIONS

0

Scholarly Papers (3)

1.

The Value of Stereotactic Radiotherapy after Folfirinox in Patients with Pancreatic Cancer with Vascular Contact – a Nationwide, Retrospective Cohort Study

Number of pages: 32 Posted: 03 Dec 2024
affiliation not provided to SSRN, Utrecht University - University Medical Center (Utrecht), affiliation not provided to SSRN, affiliation not provided to SSRN, University of Amsterdam - Amsterdam UMC, University of Amsterdam - Amsterdam University Medical Centers, Utrecht University - University Medical Center (Utrecht), affiliation not provided to SSRN, Onze Lieve Vrouwen Gasthuis, Catharina Hospital, Erasmus University Medical Center Rotterdam - Medical Oncology, Utrecht University - University Medical Center (Utrecht), Medisch Spectrum Twente, affiliation not provided to SSRN, University of Groningen - Department of Gastroenterology and Hepatology, affiliation not provided to SSRN, Radboud University, affiliation not provided to SSRN, University of Amsterdam - Amsterdam UMC, University Medical Center Utrecht, St. Antonius Hospital, Erasmus University Rotterdam (EUR) - Department of Surgery and Erasmus University Rotterdam (EUR) - Department of Surgery
Downloads 67 (907,769)

Abstract:

Loading...

Pancreatic cancer Locally advanced pancreatic cancerStereotactic body radiotherapy

2.

Developing a Predictive Model for Folfirinox Chemotherapy Response in Pancreatic Ductal Adenocarcinoma Using Conventional Circulating Biomarkers

Number of pages: 29 Posted: 04 Dec 2024
affiliation not provided to SSRN, affiliation not provided to SSRN, University of Amsterdam - Amsterdam UMC, Erasmus University Medical Center Rotterdam - Medical Oncology, Maastricht University - GROW School for Oncology and Reproduction, Erasmus University Rotterdam (EUR) - Department of Surgery, affiliation not provided to SSRN, Erasmus University Rotterdam (EUR) - Department of Surgery, affiliation not provided to SSRN and Erasmus University Rotterdam (EUR) - Department of Surgery
Downloads 52 (1,041,696)

Abstract:

Loading...

FOLFIRINOX CHEMOTHERAPY, Pancreatic cancer, Prediction model, RANDOM FOREST MODEL, Treatment response

3.

­­­A Multigene Circulating Biomarker to Predict the Lack of FOLFIRINOX Response after a Single Cycle in Patients with Pancreatic Ductal Adenocarcinoma (PDAC)

Number of pages: 29 Posted: 27 Oct 2022
Erasmus University Rotterdam (EUR) - Department of Surgery, Erasmus University Medical Center Rotterdam - Department of Pathology Unit of Tumor Immuno-Pathology, Erasmus University Rotterdam (EUR) - Department of Surgery, Erasmus University Rotterdam (EUR) - Department of Surgery, Erasmus University Rotterdam (EUR) - Department of Surgery, Erasmus University Medical Center Rotterdam - Medical Oncology, Leiden University - Department of Medical Oncology,, Erasmus University Rotterdam (EUR) - Department of Surgery and Erasmus University Medical Center Rotterdam - Department of Pathology Unit of Tumor Immuno-Pathology
Downloads 44 (1,133,231)

Abstract:

Loading...

Pancreatic ductal adenocarcinoma (PDAC), FOLFIRINOX chemotherapy, lack of response, blood immune transcriptome, FFX-ΔGEP score, precision medicine